| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | zf-C2H2 | ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433 | 8.09e-04 | 693 | 81 | 10 | PF00096 |
| Domain | ZnF_GATA | 1.19e-03 | 12 | 81 | 2 | SM00401 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433 | 1.87e-03 | 775 | 81 | 10 | PS50157 |
| Domain | Znf_GATA | 1.88e-03 | 15 | 81 | 2 | IPR000679 | |
| Domain | GATA | 1.88e-03 | 15 | 81 | 2 | PF00320 | |
| Domain | ZINC_FINGER_C2H2_1 | ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433 | 1.91e-03 | 777 | 81 | 10 | PS00028 |
| Domain | GATA_ZN_FINGER_1 | 2.14e-03 | 16 | 81 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 2.14e-03 | 16 | 81 | 2 | PS50114 | |
| Domain | Znf_C2H2-like | ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433 | 2.28e-03 | 796 | 81 | 10 | IPR015880 |
| Domain | Znf_C2H2 | ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433 | 2.47e-03 | 805 | 81 | 10 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433 | 2.54e-03 | 808 | 81 | 10 | SM00355 |
| Domain | - | ZNF668 ZNF547 ZNF335 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433 | 2.66e-03 | 679 | 81 | 9 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF668 ZNF547 ZNF335 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433 | 3.08e-03 | 694 | 81 | 9 | IPR013087 |
| Domain | KRAB | 4.62e-03 | 358 | 81 | 6 | PS50805 | |
| Domain | KRAB | 4.62e-03 | 358 | 81 | 6 | PF01352 | |
| Domain | KRAB | 5.34e-03 | 369 | 81 | 6 | SM00349 | |
| Domain | KRAB | 5.41e-03 | 370 | 81 | 6 | IPR001909 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MTA2 HSPG2 FLNC VAC14 LRFN1 GBF1 ABL1 SUGP2 CASKIN1 ZNF335 PFAS TOR4A DOCK6 SPEN CEP170B | 5.89e-08 | 1105 | 84 | 15 | 35748872 |
| Pubmed | 5.05e-07 | 653 | 84 | 11 | 22586326 | ||
| Pubmed | 7.83e-07 | 209 | 84 | 7 | 36779422 | ||
| Pubmed | HSPG2 SUGP2 RBM33 SQSTM1 TRPS1 MRPS23 RPS15 LARP1 UQCRC2 FOXA1 SPEN PCM1 TP53 SORD MRPL2 | 1.54e-06 | 1429 | 84 | 15 | 35140242 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.59e-06 | 588 | 84 | 10 | 38580884 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 2.36e-06 | 477 | 84 | 9 | 31300519 | |
| Pubmed | Insights into selective activation of p53 DNA binding by c-Abl. | 5.76e-06 | 2 | 84 | 2 | 15661746 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 35241069 | ||
| Pubmed | Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization. | 5.76e-06 | 2 | 84 | 2 | 10629029 | |
| Pubmed | The effects of c-Abl mutation on developing B cell differentiation and survival. | 5.76e-06 | 2 | 84 | 2 | 19299624 | |
| Pubmed | AMPK β1 reduces tumor progression and improves survival in p53 null mice. | 5.76e-06 | 2 | 84 | 2 | 28544264 | |
| Pubmed | Homoharringtonine promotes BCR‑ABL degradation through the p62‑mediated autophagy pathway. | 5.76e-06 | 2 | 84 | 2 | 31789418 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 34743698 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 16380437 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 35113015 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 10713716 | ||
| Pubmed | Genetic features of TP53 mutation and its downstream FOXA1 in prostate cancer. | 5.76e-06 | 2 | 84 | 2 | 35768267 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 32652042 | ||
| Pubmed | Meiotic Knockdown and Complementation Reveals Essential Role of RAD51 in Mouse Spermatogenesis. | 5.76e-06 | 2 | 84 | 2 | 28178517 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21824431 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 30674441 | ||
| Pubmed | Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers. | 5.76e-06 | 2 | 84 | 2 | 28661474 | |
| Pubmed | c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency. | 5.76e-06 | 2 | 84 | 2 | 10805805 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 35624155 | ||
| Pubmed | Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage. | 5.76e-06 | 2 | 84 | 2 | 18291097 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23660976 | ||
| Pubmed | THAP4 COL24A1 ZNF668 GBF1 TPRN ZNF335 AMOTL1 TRPS1 PFAS TP53 | 6.45e-06 | 689 | 84 | 10 | 36543142 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FLNC GBF1 SUGP2 TRPS1 LARP1 RITA1 CHD1L MRPL3 FOXA1 SPEN TP53 | 6.90e-06 | 857 | 84 | 11 | 25609649 |
| Pubmed | 1.10e-05 | 437 | 84 | 8 | 20562859 | ||
| Pubmed | MTA2 SUGP2 SQSTM1 TPRN TRPS1 BICRAL STK39 RAB11FIP1 FOXA1 CEP170B PCM1 TP53 | 1.51e-05 | 1116 | 84 | 12 | 31753913 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 20861022 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 19052872 | ||
| Pubmed | Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. | 1.73e-05 | 3 | 84 | 2 | 15526030 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11003672 | ||
| Pubmed | Deacetylation of p53 modulates its effect on cell growth and apoptosis. | 1.73e-05 | 3 | 84 | 2 | 11099047 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 28512249 | ||
| Pubmed | Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress. | 1.73e-05 | 3 | 84 | 2 | 18490454 | |
| Pubmed | Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. | 1.73e-05 | 3 | 84 | 2 | 12110584 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 16793543 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 32213661 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 14764457 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 27654922 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 35439056 | ||
| Pubmed | c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression. | 1.73e-05 | 3 | 84 | 2 | 27626309 | |
| Pubmed | The dual role of p62 in ferroptosis of glioblastoma according to p53 status. | 1.73e-05 | 3 | 84 | 2 | 35216629 | |
| Pubmed | FOXL2 and FOXA1 cooperatively assemble on the TP53 promoter in alternative dimer configurations. | 1.73e-05 | 3 | 84 | 2 | 35920317 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 19225536 | ||
| Pubmed | Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion. | 1.73e-05 | 3 | 84 | 2 | 32640214 | |
| Pubmed | Autophagy regulates apoptosis by targeting NOXA for degradation. | 1.73e-05 | 3 | 84 | 2 | 29758299 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 26969828 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 17555992 | ||
| Pubmed | TRIM13 regulates ER stress induced autophagy and clonogenic ability of the cells. | 1.73e-05 | 3 | 84 | 2 | 22178386 | |
| Pubmed | Mouse DDA3 gene is a direct transcriptional target of p53 and p73. | 1.73e-05 | 3 | 84 | 2 | 12082536 | |
| Pubmed | RAD51AP2 is required for efficient meiotic recombination between X and Y chromosomes. | 1.73e-05 | 3 | 84 | 2 | 35020426 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 27956626 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 17409407 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 15064706 | ||
| Pubmed | c-Abl tyrosine kinase activates p21 transcription via interaction with p53. | 1.73e-05 | 3 | 84 | 2 | 17339230 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 30531834 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 28634261 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 8612582 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21907923 | ||
| Pubmed | 3.28e-05 | 150 | 84 | 5 | 32423001 | ||
| Pubmed | Expression of BCL2, TP53, FOXA1, and GATA3 in pTa bladder cancer recurrence. | 3.45e-05 | 4 | 84 | 2 | 38624056 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 25445601 | ||
| Pubmed | Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta. | 3.45e-05 | 4 | 84 | 2 | 15289456 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 21573174 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 16636310 | ||
| Pubmed | c-Abl phosphorylates Hdmx and regulates its interaction with p53. | 3.45e-05 | 4 | 84 | 2 | 19075013 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 36086954 | ||
| Pubmed | The expression of p21 is upregulated by forkhead box A1/2 in p53-null H1299 cells. | 3.45e-05 | 4 | 84 | 2 | 25281925 | |
| Pubmed | p53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation. | 3.45e-05 | 4 | 84 | 2 | 18793611 | |
| Pubmed | Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylation. | 3.45e-05 | 4 | 84 | 2 | 23772552 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 34404770 | ||
| Pubmed | Abl interconnects oncogenic Met and p53 core pathways in cancer cells. | 3.45e-05 | 4 | 84 | 2 | 21455220 | |
| Pubmed | ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer. | 3.45e-05 | 4 | 84 | 2 | 21852383 | |
| Pubmed | Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy. | 3.45e-05 | 4 | 84 | 2 | 27031960 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 20122174 | ||
| Pubmed | MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity. | 3.45e-05 | 4 | 84 | 2 | 23826318 | |
| Pubmed | Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. | 3.45e-05 | 4 | 84 | 2 | 17992189 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 22729085 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 26295305 | ||
| Pubmed | A positive role for c-Abl in Atm and Atr activation in DNA damage response. | 3.45e-05 | 4 | 84 | 2 | 20798688 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 24549642 | ||
| Pubmed | RITA, a novel modulator of Notch signalling, acts via nuclear export of RBP-J. | 3.45e-05 | 4 | 84 | 2 | 21102556 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 ABL1 SLF2 SQSTM1 LARP1 RAB11FIP1 DOCK6 CEP170B PCM1 TP53 | 4.34e-05 | 861 | 84 | 10 | 36931259 |
| Pubmed | 5.58e-05 | 549 | 84 | 8 | 38280479 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 22889954 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 24808538 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 25497209 | ||
| Pubmed | Axin determines cell fate by controlling the p53 activation threshold after DNA damage. | 5.74e-05 | 5 | 84 | 2 | 19731416 | |
| Pubmed | H2AFX and MDC1 promote maintenance of genomic integrity in male germ cells. | 5.74e-05 | 5 | 84 | 2 | 29437857 | |
| Pubmed | DNA mismatch repair-dependent activation of c-Abl/p73alpha/GADD45alpha-mediated apoptosis. | 5.74e-05 | 5 | 84 | 2 | 18480060 | |
| Pubmed | A Novel Role of Proline Oxidase in HIV-1 Envelope Glycoprotein-induced Neuronal Autophagy. | 5.74e-05 | 5 | 84 | 2 | 26330555 | |
| Pubmed | AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation. | 5.74e-05 | 5 | 84 | 2 | 21057547 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 6.40e-05 | 724 | 84 | 9 | 36232890 | |
| Pubmed | MTA2 THAP4 SUGP2 RBM33 LARP1 BICRAL ATIC SPEN PCM1 TP53 SORD | 6.96e-05 | 1103 | 84 | 11 | 34189442 | |
| Pubmed | Autophagosomal Content Profiling Reveals an LC3C-Dependent Piecemeal Mitophagy Pathway. | 7.04e-05 | 33 | 84 | 3 | 29149599 | |
| Pubmed | The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination. | 8.59e-05 | 6 | 84 | 2 | 27528230 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 35046107 | ||
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433 | 1.52e-05 | 718 | 48 | 10 | 28 |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 7.09e-04 | 15 | 48 | 2 | 82 | |
| GeneFamily | Mitochondrial ribosomal proteins | 1.21e-03 | 79 | 48 | 3 | 646 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.10e-03 | 36 | 48 | 2 | 823 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-06 | 188 | 84 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 173 | 84 | 5 | 85083b9ce20351dd69aa2327ad087b848b4307ff | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 2.20e-05 | 178 | 84 | 5 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.26e-05 | 179 | 84 | 5 | 8c6a84602b079bd357c66244371eb23dd9384918 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.32e-05 | 180 | 84 | 5 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-05 | 183 | 84 | 5 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-05 | 183 | 84 | 5 | 38a54216458ad57f356bb4ddf272e1af8036ddeb | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.64e-05 | 185 | 84 | 5 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 188 | 84 | 5 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 188 | 84 | 5 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 188 | 84 | 5 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 188 | 84 | 5 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 188 | 84 | 5 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 188 | 84 | 5 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.08e-05 | 191 | 84 | 5 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.08e-05 | 191 | 84 | 5 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.08e-05 | 191 | 84 | 5 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.32e-05 | 194 | 84 | 5 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 196 | 84 | 5 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 3.57e-05 | 197 | 84 | 5 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.65e-05 | 198 | 84 | 5 | 2dc0510846cbc296a300b8465e7be9b39f479852 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Mesothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.65e-05 | 198 | 84 | 5 | eb7e674d08a7aeb554c1e4797338280581b79989 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.65e-05 | 198 | 84 | 5 | 364de83e30d842123fb92367f54b4bea57a47c84 | |
| ToppCell | Sepsis-URO-Lymphocyte-B-Plasmablast|URO / Disease, condition lineage and cell class | 3.74e-05 | 199 | 84 | 5 | 0df6cafb7f3b607cbe80b6f25b4fd62d421d01ee | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.83e-05 | 200 | 84 | 5 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.64e-05 | 197 | 80 | 6 | EFO_0005680 | |
| Disease | cholesterol in medium HDL measurement | 2.04e-05 | 59 | 80 | 4 | EFO_0021903 | |
| Disease | phospholipids in HDL measurement | 2.32e-05 | 61 | 80 | 4 | EFO_0022293 | |
| Disease | obsolete_red blood cell distribution width | NYAP2 ABL1 ZBED6 SQSTM1 PLCL2 UGT2B10 LARP1 STK39 DOCK6 ZFYVE1 TMEM40 AXIN1 SORD | 6.43e-05 | 1347 | 80 | 13 | EFO_0005192 |
| Disease | drebrin-like protein measurement | 7.22e-05 | 5 | 80 | 2 | EFO_0020333 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.03e-04 | 274 | 80 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | rho GTPase-activating protein 30 measurement | 1.51e-04 | 7 | 80 | 2 | EFO_0802012 | |
| Disease | coiled-coil domain-containing protein 80 measurement | 2.01e-04 | 8 | 80 | 2 | EFO_0020268 | |
| Disease | testis-expressed sequence 29 protein measurement | 2.01e-04 | 8 | 80 | 2 | EFO_0802125 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.51e-04 | 45 | 80 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | HEPATOCELLULAR CARCINOMA | 2.58e-04 | 9 | 80 | 2 | 114550 | |
| Disease | Adult Hepatocellular Carcinoma | 2.58e-04 | 9 | 80 | 2 | C0279607 | |
| Disease | tumor necrosis factor receptor superfamily member 16 measurement | 2.58e-04 | 9 | 80 | 2 | EFO_0802168 | |
| Disease | Hepatocellular carcinoma | 2.58e-04 | 9 | 80 | 2 | cv:C2239176 | |
| Disease | Small Lymphocytic Lymphoma | 3.22e-04 | 10 | 80 | 2 | C0855095 | |
| Disease | B-lymphoblastic leukemia/lymphoma (is_implicated_in) | 3.22e-04 | 10 | 80 | 2 | DOID:0080630 (is_implicated_in) | |
| Disease | B-CELL MALIGNANCY, LOW-GRADE | 3.22e-04 | 10 | 80 | 2 | C1868683 | |
| Disease | Ductal Carcinoma | 3.93e-04 | 11 | 80 | 2 | C1176475 | |
| Disease | hematocrit | 4.00e-04 | 1011 | 80 | 10 | EFO_0004348 | |
| Disease | phospholipids in medium HDL measurement | 4.55e-04 | 55 | 80 | 3 | EFO_0022295 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 4.55e-04 | 55 | 80 | 3 | EFO_0022288 | |
| Disease | Myeloproliferative disease | 4.71e-04 | 12 | 80 | 2 | C0027022 | |
| Disease | total lipids in medium HDL measurement | 5.32e-04 | 58 | 80 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 5.32e-04 | 58 | 80 | 3 | EFO_0022267 | |
| Disease | free cholesterol in HDL measurement | 6.17e-04 | 61 | 80 | 3 | EFO_0022264 | |
| Disease | total lipids in HDL measurement | 6.78e-04 | 63 | 80 | 3 | EFO_0022307 | |
| Disease | osteoporosis | 1.04e-03 | 73 | 80 | 3 | EFO_0003882 | |
| Disease | phospholipids in large HDL measurement | 1.04e-03 | 73 | 80 | 3 | EFO_0022190 | |
| Disease | total lipids in large HDL | 1.08e-03 | 74 | 80 | 3 | EFO_0022189 | |
| Disease | stem Cell Growth Factor beta measurement | 1.13e-03 | 75 | 80 | 3 | EFO_0008292 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.17e-03 | 169 | 80 | 4 | DOID:3908 (is_marker_for) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.20e-03 | 19 | 80 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 1.20e-03 | 19 | 80 | 2 | EFO_0003100, GO_1902519 | |
| Disease | free cholesterol in large HDL measurement | 1.31e-03 | 79 | 80 | 3 | EFO_0022157 | |
| Disease | Adenocarcinoma of prostate | 1.34e-03 | 20 | 80 | 2 | C0007112 | |
| Disease | cholesterol in large HDL measurement | 1.36e-03 | 80 | 80 | 3 | EFO_0021900 | |
| Disease | corneal resistance factor | 1.43e-03 | 451 | 80 | 6 | EFO_0010067 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 1.47e-03 | 21 | 80 | 2 | C1292769 | |
| Disease | triacylglycerol 58:9 measurement | 1.62e-03 | 22 | 80 | 2 | EFO_0010443 | |
| Disease | linoleic acid measurement | 1.66e-03 | 186 | 80 | 4 | EFO_0006807 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.76e-03 | 189 | 80 | 4 | EFO_0009932 | |
| Disease | smoking cessation | 1.92e-03 | 325 | 80 | 5 | EFO_0004319 | |
| Disease | colon adenocarcinoma (is_marker_for) | 2.09e-03 | 25 | 80 | 2 | DOID:234 (is_marker_for) | |
| Disease | Bone Diseases, Developmental | 2.44e-03 | 27 | 80 | 2 | C0005941 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 2.50e-03 | 99 | 80 | 3 | EFO_0004639, EFO_0008595 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 2.62e-03 | 28 | 80 | 2 | DOID:0050866 (is_implicated_in) | |
| Disease | opioid use disorder | 2.64e-03 | 101 | 80 | 3 | EFO_0010702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GITGMSHRARPHGIS | 71 | Q8N976 | |
| HREVRGPVLGHTATG | 6 | P59052 | |
| SSKGSGRHHILSAGP | 331 | Q99678 | |
| GHGKSPDHRGRVSSL | 926 | Q8IY63 | |
| LHRVGPGDDRHSTKS | 326 | Q9Y4F5 | |
| KPIGGHILAHASTTR | 286 | Q14565 | |
| GIHACRRGGVTLGHK | 161 | Q00796 | |
| KEGSSRTHRPGGKHG | 136 | Q96LY2 | |
| RGEHTVHVGPRGSVR | 296 | Q8TF44 | |
| HTPTRHGRNTVCGGK | 1586 | Q96BY7 | |
| HATIRGSHGGRKVPL | 26 | Q76M96 | |
| HRGIKGLVRDSHGKG | 641 | Q8N436 | |
| LLRGGSHFPHGISRV | 1106 | Q09MP3 | |
| PGVKRTVTHRTNSGG | 961 | Q96EV2 | |
| EGATRGTTEPHSRGH | 411 | O94776 | |
| KRGGSLPVRHQTHGS | 2376 | P98160 | |
| HKRGGSLPSHHQTRG | 2761 | P98160 | |
| HVLGAGPHVKRGSNT | 291 | P22695 | |
| EARPGRHGHSIKRAS | 741 | Q8WXD9 | |
| HPGGDRTGNHTSRAK | 656 | Q6PKG0 | |
| LGSHRLHPATETGGR | 191 | Q6ISU1 | |
| SHSGKRGIPHSLSGL | 1621 | Q9ULH0 | |
| VHADHGEPIGRGTKV | 146 | Q58FF7 | |
| TKRHRSTPHLDGAGG | 726 | Q9P244 | |
| RASGKPSNVGHRLGH | 81 | Q92952 | |
| KTGGTTSPKHGRAEH | 431 | Q9UPA5 | |
| GVGRRRTKTPHTFPH | 71 | Q15154 | |
| ETGHHAPGLKLRGTG | 211 | Q6UWM7 | |
| GGRHGSVSLLRHPGT | 51 | Q96MZ4 | |
| KVTGPRLSGGHSLHE | 2591 | Q14315 | |
| TGHVAGTRKTTPGFR | 131 | Q15274 | |
| GKEPGGSRAHSSHLK | 356 | P04637 | |
| AGHRVRESGHKVPVS | 321 | Q6PGN9 | |
| KERGHHGASSSREPV | 561 | Q9P242 | |
| DSPLHRGVHGKTGQL | 306 | P55317 | |
| GPEGHRKTSSRSDHG | 936 | Q6AI39 | |
| KGLLRAHGTHPAIST | 306 | Q96HP0 | |
| HRRTGHGSSGTRKPQ | 646 | O15169 | |
| ASVHLPRIGHATKGF | 836 | Q86WJ1 | |
| RRHKHSSESPGRDKG | 876 | P00519 | |
| GSHTLLGAVGEPHRR | 126 | Q6V0L0 | |
| HGRPGKIHRSATDAD | 1326 | Q92538 | |
| TLPKVHRTGAVSGHS | 86 | P03952 | |
| HSHKPDATGGRGLSR | 271 | Q9NUM3 | |
| HGQTKTHRRPGAVAT | 231 | P09001 | |
| GEARTQHGGSHVSRK | 136 | Q9Y3D9 | |
| ALSQHPHSRKGGLIG | 61 | Q08AM6 | |
| GAGTGSAKHRLHPVK | 1166 | Q6WKZ4 | |
| VHVAITNRRGGGKPH | 876 | Q9UPR0 | |
| HLRPGSTAHAAAGKR | 26 | Q8IX21 | |
| GGLHSSRPLKRGLSH | 186 | Q96K30 | |
| GKGLHRGHTKLAFPS | 156 | Q13501 | |
| SERAALERHGGHKTP | 6 | Q9Y478 | |
| EAQGIHISRHTRPKG | 186 | Q96LP6 | |
| HQLGLGGKDVRHSSP | 46 | Q17RW2 | |
| FGHRGSKQLHRGKPV | 276 | Q6P3X8 | |
| VKHGRPGIGATHSSR | 126 | P62841 | |
| HLSPGAAGSSRVKHQ | 601 | Q9UHF7 | |
| SQLRVHGGTHTGEKP | 431 | Q9H0M5 | |
| CGLTRHVRTHTGEKP | 406 | Q96MU6 | |
| APELRSHGRSHTGEK | 96 | Q96K58 | |
| ERTGGSPSVRHGSFH | 1256 | Q96T58 | |
| HRHPVAQSTDGIRGK | 76 | Q96A44 | |
| PSGHEGAAPGHTRRK | 11 | O15067 | |
| RHVGSRGGPSERSHA | 631 | Q9NS62 | |
| SKLATHRLAHGGARP | 76 | Q86XF7 | |
| GVHVPLGGRKSHRRH | 51 | Q6U841 | |
| SGTRLKHHGRQAPGL | 706 | Q8IX01 | |
| GLHHGKRVGPISAVA | 1846 | P22105 | |
| ATGKHRRSLGAGYPH | 81 | Q8WWA1 | |
| KSGGRDHTGRIRVHG | 81 | Q5T653 | |
| APGTRRHFSTSRGGH | 16 | Q5XG85 | |
| LGGRVKTLHPAVHAG | 61 | P31939 | |
| KHGGRVRTFPHERGN | 66 | Q9BQ65 | |
| RTHSGGNKRRHPVTV | 106 | Q9HBF4 | |
| SHLARHRRVHTGGKP | 666 | Q96SE7 | |
| ALHGPSGVGKSHVGR | 191 | Q9NXH8 | |
| SGVGKSHVGRLLARH | 196 | Q9NXH8 | |
| GKPGSHLGTSTLQRH | 161 | P86452 | |
| RAAGHRSHKRKLSGP | 241 | Q8N9G6 | |
| GDGGRPTFVKNHRVH | 136 | Q8IVP9 | |
| GSNSFTVHPRGLHRG | 201 | Q4KMQ1 | |
| LLGHPKTRAFITHGG | 361 | P36537 | |
| AKKVRRVPGSSGHLH | 361 | Q9UEW8 | |
| HIQRLHSPDGRKSGT | 1121 | Q9H4Z2 | |
| SNLRRHGRTHTGEKP | 631 | Q8N7K0 | |
| HLTEKKRGAGGHGRT | 86 | Q8WY91 | |
| GSLAIHRRAHTGEKP | 241 | A8K8V0 | |
| RGHARTVGHQASPIK | 181 | P59046 |